News Sentiment

FULC sentiment intelligence

Fulcrum Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 31 Cautious news tone 55 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 3.70 Week of 19 Jun 2026
Weighted tone 31/100

Cautious news tone

Market reaction Bad news being absorbed

Cautious headlines are being absorbed by price, which can signal underlying demand.

Primary event Market update

79/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+7.2% over one week, -43.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Faces Possible Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP

Market Reaction

Bad news being absorbed

80/100 confidence

Cautious headlines are being absorbed by price, which can signal underlying demand.

Primary event Market update 79/100 classification
One-week reaction 7.2% Price confirming higher
Trend fit Trend inactive -43.7% over four weeks
Fair value -43.3% Below fair value
Caution agrees with inactive trend

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 4
Neutral 26
Negative 25

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
Stock Titan 8
ACCESS Newswire 5
NewMediaWire 4
TradingKey 3
simplywall.st 3
Investing.com 3
PR Newswire 2

Event Lens

What the news is about

Classified themes
Market update 29
Regulatory and legal 12
Earnings 8
Deals and strategy 3
Analyst action 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-55 of 55